P
| Pap smear |
| Parainfluenza type 1 (PIV-1) |
| Parainfluenza type 2 (PIV-2) |
| Parainfluenza type 3 (PIV-3) |
| Parainfluenza type 4 (PIV-4) |
| ParvoVirous B19 |
| PDGFRB(5q33) for Myeloid and Lymphoid Neoplasms with Eosinophilia (HES/CEL) |
| Plasma Cell Leukemia panel at diagnosis ( 12-16 CD markers) |
| Plasma Cell Leukemia panel for MRD ( 8-12 CD markers) |
| Plasma Cell Myeloma panel at diagnosis ( 12-16 CD markers) |
| Plasma Cell Myeloma panel for MRD ( 8-12 CD markers) |
| Plasminogen Activator Inhibitor-1 (PAI-1) gene 675 4G/5G |
| Plasminogen Activator Inhibitor-1 (PAI-1) gene 844 A/G |
| Plasmodium falciparum |
| Plasmodium vivax |
| Plavix or Clopidogrel resitance or Cyp2c19 Genotyping for Plavix or Clopidogrel – Genotype 2 |
| Plavix or Clopidogrel resitance or Cyp2c19 Genotyping for Plavix or Clopidogrel – Genotype 3 |
| PLZF-RARA |
| PML/RARA t(15;17)(15q24,17q21) for AML-M3 |
| Pneumocystis jiroveci (carinii) |
| Pneumocystis jiroveci (carinii) |
| PNH Panel Granulocyte/Monocyte & Erytrocyte (10-14 CD markers) |
| Prothrombin (Factor II)/ G20210A Mutation |